The global pharmaceutical industry relies heavily on a robust supply chain of high-quality chemical intermediates. At NINGBO INNO PHARMCHEM CO.,LTD., we recognize that the consistent availability and purity of compounds like Benzyl (1-cyano-1-methylethyl)carbamate (CAS: 100134-82-5) are fundamental to the successful development and manufacturing of essential medicines. This particular chemical, also referred to by its synonym benzyl N-(2-cyanopropan-2-yl)carbamate, is a critical component in the synthesis of advanced antiviral drugs.

Understanding the intricacies of benzyl (1-cyano-1-methylethyl)carbamate synthesis is key for any organization involved in pharmaceutical production. The compound's molecular formula C12H14N2O2 and molecular weight of 218.25200 are important identifiers for chemists. The specification of u226598.0% assay signifies a high level of purity, ensuring that it meets the stringent requirements for use in pharmaceutical manufacturing, especially for intermediates used in the raltegravir intermediate production process. This commitment to quality is what NINGBO INNO PHARMCHEM CO.,LTD. offers its clients.

When considering the market for pharmaceutical building blocks manufacturing, Benzyl (1-cyano-1-methylethyl)carbamate plays a significant role. Its function as one of the primary antiviral drug synthesis building blocks makes it highly sought after. Buyers often search for detailed information on cas 100134-82-5 chemical properties to ensure compatibility and efficiency in their production lines. The compound's physical characteristics, such as its appearance as a white to off-white powder, are also important for handling and quality control.

The strategic sourcing of pharmaceutical intermediates for HIV drugs like this one is a critical aspect of supply chain management. NINGBO INNO PHARMCHEM CO.,LTD. strives to be a reliable partner, providing not only the chemical itself but also the assurance of quality and consistency. By focusing on compounds like Benzyl (1-cyano-1-methylethyl)carbamate, we empower pharmaceutical innovators to develop and deliver life-saving treatments, contributing to global health advancements through chemical excellence.